Anna Pagonakis

Array ( [id] => 4933543 [patent_doc_number] => 20080004318 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-01-03 [patent_title] => 'Substituted Bicyclic and Tricyclic Thrombin Receptor Antagonists' [patent_app_type] => utility [patent_app_number] => 11/769018 [patent_app_country] => US [patent_app_date] => 2007-06-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19098 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0004/20080004318.pdf [firstpage_image] =>[orig_patent_app_number] => 11769018 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8446316 [patent_doc_number] => 08288369 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-10-16 [patent_title] => 'Delta-tocotrienol treatment and prevention of pancreatic cancer' [patent_app_type] => utility [patent_app_number] => 11/768373 [patent_app_country] => US [patent_app_date] => 2007-06-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 38 [patent_figures_cnt] => 49 [patent_no_of_words] => 13375 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11768373 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8146755 [patent_doc_number] => 08163760 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-04-24 [patent_title] => 'Use of pyridopyrimidine compounds in the treatment of gliomas' [patent_app_type] => utility [patent_app_number] => 12/306202 [patent_app_country] => US [patent_app_date] => 2007-06-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 7 [patent_no_of_words] => 14954 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/163/08163760.pdf [firstpage_image] =>[orig_patent_app_number] => 12306202 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4670492 [patent_doc_number] => 20080045552 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-02-21 [patent_title] => 'Methods of using selective chemotherapeutic agents for targeting tumor cells' [patent_app_type] => utility [patent_app_number] => 11/820872 [patent_app_country] => US [patent_app_date] => 2007-06-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 2544 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0045/20080045552.pdf [firstpage_image] =>[orig_patent_app_number] => 11820872 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5570346 [patent_doc_number] => 20090253724 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-08 [patent_title] => 'THERAPEUTIC OR PROPHYLACTIC AGENT FOR LEUKEMIA' [patent_app_type] => utility [patent_app_number] => 12/305646 [patent_app_country] => US [patent_app_date] => 2007-06-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 33411 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0253/20090253724.pdf [firstpage_image] =>[orig_patent_app_number] => 12305646 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6569516 [patent_doc_number] => 20100234441 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-16 [patent_title] => 'NOVEL COMPOUNDS' [patent_app_type] => utility [patent_app_number] => 12/303791 [patent_app_country] => US [patent_app_date] => 2007-06-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 44716 [patent_no_of_claims] => 46 [patent_no_of_ind_claims] => 23 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0234/20100234441.pdf [firstpage_image] =>[orig_patent_app_number] => 12303791 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4705142 [patent_doc_number] => 20080064666 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-03-13 [patent_title] => 'CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR PROTEIN INHIBITORS AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 11/761295 [patent_app_country] => US [patent_app_date] => 2007-06-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 20491 [patent_no_of_claims] => 55 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0064/20080064666.pdf [firstpage_image] =>[orig_patent_app_number] => 11761295 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6638386 [patent_doc_number] => 20100173941 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-08 [patent_title] => 'Muscarinic Receptor Agonists that are Effective in the Treatment of Pain, Alzheimer\'s Disease and Schizophrenia' [patent_app_type] => utility [patent_app_number] => 12/303637 [patent_app_country] => US [patent_app_date] => 2007-06-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10033 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0173/20100173941.pdf [firstpage_image] =>[orig_patent_app_number] => 12303637 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5373688 [patent_doc_number] => 20090311249 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-17 [patent_title] => 'Capecitabine Combination Therapy' [patent_app_type] => utility [patent_app_number] => 12/227656 [patent_app_country] => US [patent_app_date] => 2007-06-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 19564 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0311/20090311249.pdf [firstpage_image] =>[orig_patent_app_number] => 12227656 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7682239 [patent_doc_number] => 20100022569 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-28 [patent_title] => 'INHIBITORS OF TYROSINE KINASES' [patent_app_type] => utility [patent_app_number] => 12/301690 [patent_app_country] => US [patent_app_date] => 2007-05-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5738 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0022/20100022569.pdf [firstpage_image] =>[orig_patent_app_number] => 12301690 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5198811 [patent_doc_number] => 20070298129 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-12-27 [patent_title] => 'Compounds and compositions for treating neuronal death or neurological dysfunction' [patent_app_type] => utility [patent_app_number] => 11/804588 [patent_app_country] => US [patent_app_date] => 2007-05-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 40 [patent_figures_cnt] => 40 [patent_no_of_words] => 19811 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0298/20070298129.pdf [firstpage_image] =>[orig_patent_app_number] => 11804588 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4705193 [patent_doc_number] => 20080064717 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-03-13 [patent_title] => 'Inhibitors of diacylglycerol O-acyltransferase type 1 enzyme' [patent_app_type] => utility [patent_app_number] => 11/749952 [patent_app_country] => US [patent_app_date] => 2007-05-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 43158 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0064/20080064717.pdf [firstpage_image] =>[orig_patent_app_number] => 11749952 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4894096 [patent_doc_number] => 20080103195 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-05-01 [patent_title] => 'COMPOUNDS FROM ANTRODIA CAMPHORATA FOR INHIBITING THE GROWTH OF CANCER TUMOR CELLS' [patent_app_type] => utility [patent_app_number] => 11/749659 [patent_app_country] => US [patent_app_date] => 2007-05-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4444 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0103/20080103195.pdf [firstpage_image] =>[orig_patent_app_number] => 11749659 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9691931 [patent_doc_number] => 08822526 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-09-02 [patent_title] => 'Synergistic pharmaceutical combination for the treatment of cancer' [patent_app_type] => utility [patent_app_number] => 12/600019 [patent_app_country] => US [patent_app_date] => 2007-05-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 12420 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 66 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12600019 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7774830 [patent_doc_number] => 08119795 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-02-21 [patent_title] => 'Triazole derivatives II' [patent_app_type] => utility [patent_app_number] => 12/301140 [patent_app_country] => US [patent_app_date] => 2007-04-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26923 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/119/08119795.pdf [firstpage_image] =>[orig_patent_app_number] => 12301140 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5210046 [patent_doc_number] => 20070248630 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-10-25 [patent_title] => 'PHARMACEUTICAL FORMULATIONS FOR IONTOPHORETIC METHOTREXATE DELIVERY' [patent_app_type] => utility [patent_app_number] => 11/737568 [patent_app_country] => US [patent_app_date] => 2007-04-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 2617 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0248/20070248630.pdf [firstpage_image] =>[orig_patent_app_number] => 11737568 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4677049 [patent_doc_number] => 20080214680 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-04 [patent_title] => 'Application of arsenic as a cancer prevention agent' [patent_app_type] => utility [patent_app_number] => 11/788306 [patent_app_country] => US [patent_app_date] => 2007-04-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4815 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0214/20080214680.pdf [firstpage_image] =>[orig_patent_app_number] => 11788306 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6248791 [patent_doc_number] => 20100137239 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-03 [patent_title] => 'GEMCITABINE COMBINATION THERAPY' [patent_app_type] => utility [patent_app_number] => 12/298265 [patent_app_country] => US [patent_app_date] => 2007-04-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 36605 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0137/20100137239.pdf [firstpage_image] =>[orig_patent_app_number] => 12298265 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5101808 [patent_doc_number] => 20070185070 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-08-09 [patent_title] => 'Novel PPAR ligands that do not cause fluid retention, edema or congestive heart failure' [patent_app_type] => utility [patent_app_number] => 11/784436 [patent_app_country] => US [patent_app_date] => 2007-04-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21628 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0185/20070185070.pdf [firstpage_image] =>[orig_patent_app_number] => 11784436 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5552817 [patent_doc_number] => 20090286803 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-11-19 [patent_title] => 'COMBINATION COMPRISING A) A PYRIMIDYLAMINOBENZAMIDE COMPOUND, AND B) A THR315LLE KINASE INHIBITOR' [patent_app_type] => utility [patent_app_number] => 12/295812 [patent_app_country] => US [patent_app_date] => 2007-04-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6234 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0286/20090286803.pdf [firstpage_image] =>[orig_patent_app_number] => 12295812 [rel_patent_id] =>[rel_patent_doc_number] =>)